← Leaderboards
Emily W Baker
Aruna Biomedical, Inc.
$4,932,488
Attributed
$4,932,488
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.9M · FY2019–25$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,932,488 · 2
By mechanism
R44$4,532,491 · 1
R43$399,997 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Safety”
- Beth Baseler · Leidos Biomedical Research, Inc.$225,257,316
- Kimberly Smith · Ppd Development Lp$122,008,792
- Klaus Romero · Critical Path Institute$90,404,592
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$75,904,237
- Yunda Huang · Fred Hutchinson Cancer Center$70,809,823
- Leonard Freedman · Leidos Biomedical Research, Inc.$64,938,611
Research focus
SafetyIschemic StrokeInnovationResponseStroke TherapyNerve Stem CellExtracellular VesiclesHourLesionRattusSmall Business Innovation Research GrantStrokeExosomeNeuronsBloodAcuteFundingBrain TissueCommercializationAgedBiologicalDrug Or Chemical Tissue DistributionDoseDiffusion
Grant awards (4)
Neural exosome therapeutics for treating opioid-induced brain hypoxia injuries$399,997
R43 · FY2025 · DA · contact PI
Human Neural Cell Exosomes as a Therapeutic Treatment for Stroke$347,398
R44 · FY2023 · NS · contact PI
Human Neural Cell Exosomes as a Therapeutic Treatment for Stroke$1,304,996
R44 · FY2020 · NS · contact PI
Human Neural Cell Exosomes as a therapeutic treatment for stroke$2,880,097
R44 · FY2019 · NS · contact PI